Trekka Therapeutics, Inc.
PrivateLast Round
Series A
Feb 5, 2024
Total Funding Raised
$548,000
Company Overview
Trekka Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Saint Paul, Minnesota. It has raised $548,000.
Trekka Therapeutics, Inc. is a biotechnology company that develops proprietary polymeric drug delivery platforms, CAPRO™ and MORE™, to improve the formulation, solubility, and delivery of small molecule drugs and biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trekka Therapeutics, Inc. Comparables
Compare Trekka Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Consegna Pharma Inc. | 81% | |
| CURE Pharmaceutical | 77% | |
| Nualtis | 77% |
For institutional investors. Book with your work email.
Trekka Therapeutics, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Trekka Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
Trekka Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trekka Therapeutics, Inc.'s valuation, stock price, and market status.
Is Trekka Therapeutics, Inc. a public or private company?
Trekka Therapeutics, Inc. is a private company.
What is the current stock price of Trekka Therapeutics, Inc.?
Trekka Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Trekka Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trekka Therapeutics, Inc. worth (valuation)?
Valuation information for Trekka Therapeutics, Inc. is not publicly available.
Can I buy Trekka Therapeutics, Inc. stock?
Trekka Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trekka Therapeutics, Inc.'s last funding round?
Trekka Therapeutics, Inc.'s most recent funding round was Series A on February 5, 2024.
Who are the main investors in Trekka Therapeutics, Inc.?
Key investors in Trekka Therapeutics, Inc. include NIH RADx.
Will Trekka Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Trekka Therapeutics, Inc..
How can I track Trekka Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Trekka Therapeutics, Inc.'s shares on secondary markets.